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articular cartilage after six weeks of forced running on a treadmill.
However, the changes were less severe in Dcn-/- compared to WT mice
(Mankin score 4.5 (Dcn-/-) versus 6.5 (WT)). In juvenile and adult, but
not newborn Dcn-/- mice, staining of cartilage for highly sulfated GAGs
via Alcian blue (pH 1.0) revealed an increased intensity compared to
WT mice. Likewise, the use of an antibody against chondroitin-4-sul-
fate (C4S) stubs (Δ) showed a comparably enhanced staining pattern in
Dcn-/- mice. In contrast, we found no differences in staining for pro-
teoglycan core proteins (e.g. aggrecan, biglycan, versican) or collagens
(II, VI, IX, X). At the mRNA-level, Dcn-/- mice exhibited an increased
expression of PAPS-synthase-1 (PAPSS-1), chondroitin-4-sulfo-
transferase-1 (C4ST-1) and chondroitin-4-sulfotransferase-2 (C4ST-2),
which are involved in GAG modiﬁcation. This was also true at the
protein level as visualized via staining for PAPSS-1 and ΔC4S. More-
over, AFM analysis of articular cartilage sections of three months-old
mice revealed an increased compressive stiffness of decorin-deﬁcient
articular cartilage. Those abnormalities were accompanied by
enhanced levels of active TGF-b1 in decorin-deﬁcient chondrocytes in
vitro.
Conclusions: We propose the following mechanism of OA-attenuation
in Dcn-/- mice: Decorin sequesters the cytokine TGF-b in the extrac-
ellular matrix. Higher levels of active TGF-b in cartilage of Dcn-/- mice
are likely to prevent inappropriate chondrocyte hypertrophy and,
hence, induction of osteoarthritis. TGF-b also triggers increased sulfa-
tion of GAG chains, via an upregulation of PAPSS-1, C4ST-1 and C4ST-2
and consequently a stiffer cartilage matrix. Therefore, decorin-deﬁcient
animals are less prone to develop osteoarthritis due to a combination of
elevated levels of TGF-b-activity and enhanced compressive stiffness of
the tissue.
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CTGF IS RELEASED FROM THE PERICELLULAR MATRIX OF ARTICULAR
CARTILAGE UPON MECHANICAL INJURY, AND CONTROLS THE
BIOAVAILABILITY OF TGFb
X. Tang, C. McLean, A. Chanalaris, T.L. Vincent. Univ. of Oxford, Oxford,
United Kingdom
Purpose: Work from our lab has identiﬁed an important role for the
pericellular matrix (PCM) in the mechanosensitive release of seques-
tered regulatory molecules such as FGF2. (Vincent et al. 2007). A pro-
teomic analysis of PCM proteins also identiﬁed connective tissue
growth factor (CTGF also known as CCN2). CTGF is signiﬁcantly elevated
in osteoarthritis (OA) (Hermansson et al. 2004) but its role in cartilage is
obscure. We investigated the control of the release of CTGF in cartilage,
and its biological function.
Methods: His-tagged human recombinant CTGF protein was stably
expressed in HEK293 cells and puriﬁed using nickel afﬁnity chro-
matography. To look for novel gene targets a microarray study was
performed on isolated human articular chondrocytes (HACs) with or
without CTGF stimulation. Target genes were validated by real time
PCR. Phosphorylation of SMADs was examined by western blot. The
dependence of SMAD phosphorylation and gene regulation on TGFb
was examined using a TGFb neutralising antibody and the TGFb type
I receptor inhibitor SB431542. For injury studies, porcine cartilage
was either explanted into serum free DMEM for up to 24h, or was
rested (48 hours) and then re-cut in fresh serum free DMEM for
different time periods. Both explantation and re-cut conditioned
media were collected and analysed under either reducing or non-
reducing conditions. Articular cartilage was examined by confocal
microscopy for CTGF and the latency associated peptide of TGFb
(LAP).
Results: In the microarray study, we identiﬁed four genes that were
strongly up-regulated by CTGF in human chondrocytes. All genes were
known to be TGFb inducible and their expression showed a similar
temporal pattern to TGFb. CTGF was able to activate SMAD2 in porcine
chondrocytes. Both CTGF induced gene expression and SMAD2 phos-
phorylation was abrogated by TGFb neutralising antibody and the
receptor inhibitor SB431542, suggesting that CTGF activity was TGFb
dependent. Adding exogenous CTGF to rested porcine cartilage for 1 or
4 hours, led to increased TGFb protein in the medium but no sig-
niﬁcant change in the mRNA level of TGFb. Injury to porcine cartilage
by explantation or re-cutting caused rapid massive accumulation of
endogenous CTGF in the conditioned medium (within 5 minutes),
followed by a delayed accumulation of TGFb (from 1 hour). Theaccumulation of both proteins in response to injury occurred in the
presence of cycloheximide, suggesting proteins were released from a
pre-formed pool rather than by new protein synthesis. When we
analysed the explantation conditioned medium under non-reducing
condition, CTGF was found to migrate at 150KDa along with compo-
nents of the latent TGFb complex (LAP). Although TGFb was not evi-
dent by western blot under non-reducing conditions, it was clearly
present when the same medium was run under reducing conditions
suggesting that TGFb was also tied up in the high molecular weight
complex. This was supported by the observation that the explantation
conditioned medium was able to activate SMAD2, and this activity
resided in a high molecular (>50kDa) fraction. Confocal microscopy
revealed that CTGF was present in the pericellular matrix as was the
latent complex of TGFb.
Conclusions: Our results show that pericellular CTGF, like FGF2, is
released from the matrix upon cartilage injury. The latent complex of
TGFb is also in the pericellular matrix and released with CTGF upon
injury. The temporal sequence suggests that CTGF is released ﬁrst and
then contributes to the release of latent TGFb, although it is possible
that both CTGF and TGFb are already bound and are released simulta-
neously upon injury. Either way we have described a novel pathway by
which cartilage injury controls the bioavailability of TGFb through
matrix bound CTGF.
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GALECTIN 3 HAD A PROTECTIVE ROLE IN MURINE OSTEOARTHRITIS
INDUCED BY MENISCECTOMY AND AGING
N. Hafsia. Unite 606 Inserm, Paris, France
NHafsia 1; F Poirier2; D Delacour 2; P Reboul 3; D Co^me 1; P Van Lent 4;
M Cohen-Solal 1; F Liote 1; HK Ea1
Purpose: Osteoarthritis (OA) is the most common adult joint disease
characterized by cartilage destruction, subchondral bone remodelling
andmild synovial inﬂammation. Pathogenesis of OA involves mechanic,
age and genetic factors. Galectin 3 (Gal3) expression is increased in OA
cartilage and synovial ﬂuid. Gal3 is involved in multiple cellular func-
tions including proliferation, differentiation and cell death. During
embryogenesis, the growth plate of Gal3 mutant mice has a reduction of
hypertrophic zone and many lacunae due to a loss of chondrocytes.
These results suggest a role of Gal3 in chondrocyte differentiation. The
aim of this study is to determine the role of Gal3 in osteoarthritis and to
assess its functions in chondrocyte biology.
Methods: Invivo,murineOAwas induced inWild type (WT)129andGal3
mutant mice by partial medial meniscectomy (MNX) of the right knee. A
sham operationwas performed on the left knee. Animals were sacriﬁced
4 weeks after surgery. Cartilages lesions were assessed by according to
OARSI recommendations. Chondrocyte apoptosiswas assessed by TUNEL
labelling and chondrocyte catabolism by immunostaining for aggreca-
nases and metalloproteases. Subchondral bone modiﬁcations were
evaluated by microCT. In parallel, we assessed joint lesions durinbg
ageing in 14 month old mice. In vitro, primary murine chondrocytes,
isolated from new born WT and Gal3 mutant mice, were cultured and
stimulated by inﬂammatory cytokines (IL-1b and TNF-a). Anabolism,
catabolic and differentiation responses were assessed by RT-qPCR.
Results: In vivo, MNX induced in Gal3 mutant mice more severe OA
cartilage lesions compared to WT as assessed by OARSI scoring (4.43 
1.02 vs 1.30 0.77, p<0.05). Expression Gal3 decreased inWTcartilages
after MNX compared to sham operated cartilage (34.5%  4.9 vs 53% 
2.8; p<0.01). Cartilages lesions were associated with higher ratio of
chondrocyte positive-TUNEL staining in Gal3 mutant cartilages com-
pared to WT (17.7%  6.2 vs 10.6%  3.3 p<0.02). Similarly, immunos-
taining for ADAMTS-5 (26.7%  0.5 vs 16%  1.4, p<0.02) and VDIPEN
(52%  4 vs 30%  2 ; p<0.05) was increased in Gal3 mutant cartilages.
Moreover, collagen type X expression was increased in Gal3 mutant
cartilage. No difference was observed in subchondral bone mod-
iﬁcations. Finally, Gal3 mutant mice developed spontaneous OA carti-
lage lesions at 14 months old. In vitro, IL-1b stimulation increased
ADAMTS-4(4.58 1.97 vs; 1.60 0.28 ; p<0.05) and ADAMTS-5 (4.52
2.19 vs 1.78  1 ; p<0.05)mRNA expressions in Gal3 mutant chon-
drocytes compared to WT chondrocytes.
Conclusion: Gal3 deletion exacerbated murine OA lesions induced by
mechanical stress and by ageing. OA lesions were associated with
increased chondrocyte catabolism, differentiation and death. These
results suggested Gal3 had a protective role in OA and chondrocyte
homeostasis.
